Essai clinique
Récupéré
Publication
clinicaltrials.gov
Massachusetts General Hospital, Massachusetts Institute of Technology
(2018).
Improving Driving in Young People With Autism Spectrum Disorders.
ClinicalTrials.gov.
Massachusetts General Hospital.
- Date de publication
-
31/10/2018
- Identifiant
-
NCT03538431
- Auteurs
-
Massachusetts General Hospital,
Massachusetts Institute of Technology
- Source
- ClinicalTrials.gov
- Type de référence
- clinical_trial
- Éditeur
- Massachusetts General Hospital
- Source de métadonnées
- clinicaltrials.gov
Résumé
This study will examine the effects of treatment with the anti-anxiety medicine buspirone on driving performance (eye tracking) in individuals with high-functioning autism spectrum disorder (HF-ASD). The study consists of an Assessment Visit at Massachusetts General Hospital (MGH), as well as two Driving Simulation visits that will take place at Massachusetts Institute of Technology (MIT). Subjects will be given buspirone and asked to take the medication for the two days preceding the Driving Simulation Visit.